from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1485/hemZ

LFCtreatmentdescriptionclass of inhibitor

-0.196

Amikacinug/mL Amikacintranslation

1.128

Cap5-10ug/mL Capreomycintranslation

-0.069

Rox10-50 ug/mL Roxithromycintranslation

1.634

SM2-5 ug/mL Streptomycintranslation

-2.658

Tet5-10 ug/mL Tetracyclinetranslation

0.175

Rif0.2-5ug/mL Rifampicintranscription

-0.706

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.334

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.102

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.278

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.345

Clofazimine10-13 ug/mL Clofaziminerespiration

0.640

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.789

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.584

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.580

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.018

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.713

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.159

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.801

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.439

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.642

KCN5-20 ug/mL Potassium cyaniderespiration

-0.273

NaN30.2-2 mM Sodium aziderespiration

-0.169

Nigericin50 uM Nigericinrespiration

-0.557

TRC10-150 ug/mL Triclosanrespiration

-0.050

TRZ10-25 ug/mL Thioridazinerespiration

0.030

Valinomycin0.5-10 uM Valinomycinrespiration

-0.122

ZnSO42 mM ZnSO4respiration

-0.514

menadione6-10 ug/mL Menadionerespiration

0.128

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.236

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.629

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.183

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.203

NRP_1Non-replicating persistence stage 1dosRassociated

0.270

Amp0.2mg/mL AmpicillincellWall

-0.343

Cephalexin20-100 ug/mL CephalexincellWall

0.868

Cerulenin0.32-5 ug/mL CerulenincellWall

0.623

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.540

EMB10-20 ug/mL EthambutolcellWall

-0.845

Eta12-40 ug/mL EthionamidecellWall

0.356

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.039

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.011

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.304

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.333

BZA0.12 mg/mL BenzamidearomaticAmides

0.238

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.667

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.397

H2O24 mM hydrogen peroxideDNAdamaging

-0.345

Levo10 ug/mL LevofloxacinDNAdamaging

0.629

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.034

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.009

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.770

UVUV-irradiationDNAdamaging

-0.421

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.562

Antimycin12.5-50 ug/mL Antimycin A?

0.142

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.091

PA_110-50 ug/mL Antitubercular compound PA-1?

0.056

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.667

PA8240.2-2 ug/mL PA-824?

0.225

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.224

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.249

Verapamil50 uM Verapamil?

0.921

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.175

methoxatin10-20 ug/mL Methoxatin?